Risks associated with modern drugs expand and develop beyond our existing control and perception mechanisms. New medicines have the ability to transform side effects from the traditional individual physical level to a societal level in the form of economic, political and ethical consequences. Existing assessment methods cannot capture or cope with the side effects we will experience with tomorrow's drugs. We interpret this as a sign of the need for on-going methodological developments within Medical Technology Assessment (MTA) to capture and include the as yet 'unknown' and 'unforeseen' economic, political and ethical risks of modern drugs. In this paper, we argue that a propsective inter-disciplinary approach should be applied to MTA as a form of 'early warning system', using the Delphi method combined with prospective scenarios to keep up with the changing characteristics of new drugs.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
The Royal Danish School of Pharmacy, Department of Social Pharmacy, Universitetsparken 2, DK-2100 Copenhagen
Institute for Alternative Futures, 100 N. Pitt Street Suite 235, Alexandria, VA 22314
Publication date: 2003-03-01
More about this publication?